Add BrightSurf on Google Email

IMBA- Institute of Molecular Biotechnology of the Austrian Academy of Sciences


Unlocking the secrets of the brain’s dopaminergic system

A new organoid model replicates the dopaminergic system's structure, connectivity, and functionality, shedding light on its intricate functionality and potential implications for Parkinson’s disease. The model also uncovers the enduring effects of chronic cocaine exposure on the dopaminergic circuit, even after withdrawal.

First multi-chamber heart organoids unravel human heart development and disease

Researchers create a new, multi-chamber organoid model of the human heart, enabling them to advance screening platforms for drug development, toxicology studies, and understanding heart development. The model reveals intricate communication between chambers and provides insight into early heart development.

CHOOSEn fate: one brain organoid’s tale on Autism

Researchers developed a technique called CHOOSE that allows them to test the effect of multiple mutations in parallel and at a single-cell level within human brain organoids. The study identified critical transcriptional changes regulated through common networks, or GRNs, and found that some cell types are more susceptible to autism mu...

Virus-like transposons wage war on the species barrier

Researchers from IMBA identify a family of virus-like transposons called Mavericks that facilitate horizontal gene transfer (HGT) between reproductively isolated worm species. The study reveals the role of Mavericks in overcoming the species barrier, with potential applications in pathogen control and genomic innovation.

Weiss-Kruszka syndrome and the failure to establish neuronal identity

Researchers identified the molecular mechanism underlying Weiss-Kruszka syndrome, a rare neurodevelopmental disorder characterized by craniofacial anomalies and autistic features. The study reveals that the ZFP462 gene mutation leads to a failure to safeguard neural lineage specification during early embryonic development.

SourceIMBA- Institute of Molecular Biotechnology of the Austrian Academy of Sciences·JournalNature Cell Biology·TypeExperimental study·DateJan 5, 2023

Old drugs hint at new ways to beat chronic pain

A newly identified link between chronic pain and lung cancer in mice suggests that old drugs such as clonidine, capsaicin, and fluphenazine may offer new treatments for chronic pain. The study found that blocking the BH4 pathway reduced pain sensitivity and decreased tumor growth in mouse models of KRAS-driven lung cancer.

SourceIMBA- Institute of Molecular Biotechnology of the Austrian Academy of Sciences·JournalScience Translational Medicine·TypeExperimental study·DateAug 31, 2022

How the genome is packed into chromosomes that can be faithfully moved during cell division

The Gerlich Group at IMBA found that histone acetylation establishes a sharp surface boundary on chromosomes, resisting microtubule perforation. Chromatin phase separation and DNA looping by condensin cooperates to build mitotic chromosomes with unique physical properties.

The beginning of life: The early embryo is in the driver's seat

Researchers using 'blastoids' - in vitro models of the blastocyst - discovered that early embryonic signals induce placental development and prepare the uterus. The findings may contribute to a better understanding of human fertility and potentially improve IVF procedures, fertility drugs, and contraceptives.

Double agents: How stomach stem cells change allegiance upon injury

A molecular switch, p57, enables stomach stem cells to change allegiance from normal digestion to injury response, potentially leading to new treatments for gastric pathologies. The study's findings suggest that p57 is a key regulator of reserve stem cell state in gastric chief cells.

Breakthrough research on human embryo models paves the way for improving in vitro fertilization success rate and new non-hormonal, user-friendly contraception

Researchers have discovered molecules that could be candidates for contraceptives or fertility enhancers using human blastoid models. These models also show promise in improving the self-organization of stem cells during IVF procedures.